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Summary
Standard nutritional treatment of moderate acute malnutrition (MAM) relies on fortified blended flours
though their importance to treat this condition is a matter of discussion. With the newly introduced
World Health Organization growth standards, more children at an early stage of malnutrition will be
treated following the dietary protocols as for severe acute malnutrition, including ready-to-use thera-
peutic food (RUTF). We compared the effectiveness of RUTF and a corn/soy-blend (CSB)-based
pre-mix for the treatment of MAM in the supplementary feeding programmes (SFPs) supported by
Me ´ decins Sans Frontie ` res, located in the Zinder region (south of Niger). Children measuring 65 to
<110cm, newly admitted with MAM [weight-for-height (WHM%) between 70% and <80% of the
NCHS median] were randomly allocated to receive either RUTF (Plumpy’Nut, 1000kcalday
 1)o ra
CSB pre-mix (1231kcalday
 1). Other interventions were similar in both groups (e.g. weekly family
ration and ration at discharge). Children were followed weekly up to recovery (WHM%   85% for 2
consecutive weeks). In total, 215 children were recruited in the RUTF group and 236 children in the
CSB pre-mix group with an overall recovery rate of 79.1 and 64.4%, respectively (p<0.001). There was
no evidence for a difference between death, defaulter and non-responder rates. More transfers to the
inpatient Therapeutic Feeding Centre (I-TFC) were observed in the CSB pre-mix group (19.1%)
compared to the RUTF group (9.3%) (p¼0.003). The average weight gain up to discharge was
1.08gkg
 1day
 1 higher in the RUTF group [95% confidence interval: 0.46–1.70] and the length of
stay was 2 weeks shorter in the RUTF group (p<0.001). For the treatment of childhood MAM in
Niger, RUTF resulted in a higher weight gain, a higher recovery rate, a shorter length of stay and a
lower transfer rate to the I-TFC compared to a CSB pre-mix. This might have important implications
on the efficacy and the quality of SFPs.
Key words: child nutrition disorder, wasting, fortified blended flour, ready-to-use therapeutic food,
Niger, randomized controlled trial.
Introduction
Standard nutritional treatment of moderate acute
malnutrition (MAM) relies on fortified blended
flours though their importance to treat this condition
is a matter of discussion [1]. With the newly intro-
duced World Health Organization (WHO) growth
standards [2], nutritional programmes formerly
using the weight-for-height percentage of the
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Statistics (NCHS) reference] may expect to admit
up to eight times more severely malnourished chil-
dren (Z-score WHO reference) switching from the
NCHS moderately malnourished category [3].
Consequently, those children, previously classified
as moderately malnourished, will be treated follow-
ing the dietary protocols as for severe acute malnu-
trition, including ready-to-use therapeutic food
(RUTF).
Made from peanuts, powder milk, sugar, vegetable
oil, vitamins and minerals, RUTFs have important
advantages compared to fortified blended flours.
They are energy-dense pastes that do not require
any preparation before consumption. Also, they are
manufactured in individual packages, easy to store
and to preserve from bacterial contamination.
In Malawi, three studies have evaluated the superior-
ity of RUTF on standard therapy for the treatment
of moderately wasted children [4, 5] or for children at
risk of manutrition [6]. All showed a better recovery
rate and a higher weight gain for RUTF. In 2006,
Me ´ decins Sans Frontie ` res (MSF) started to use
RUTFs in its home-based Supplementary Feeding
Programme (SFP) in Niger with encouraging
results [7].
There is a crucial need to develop and evaluate
specific treatment for children at an early stage of
acute malnutrition and, in the meantime, it is import-
ant to evaluate the effectiveness of available RUTFs
in the rehabilitation of those children. We compared
the clinical effectiveness of RUTF and a corn/
soy-blend (CSB)-based pre-mix for the treatment of
moderately malnourished children in Niger.
Material and Methods
Study setting
The study was conducted in two Supplementary
Feeding Centres (SFCs) supported since 2006 by
MSF in the remote and difficult-to-access villages
of Mallawa and Bangaza (Magaria department,
Zinder region, South of Niger). These two SFCs
were part of a larger programme with a total of 14
Ambulatory Therapeutic Feeding Centres and 2 in-
patient Therapeutic Feeding Centres (I-TFC). The
area is affected by chronic food insecurity marked
each year with a ‘hunger gap’, period when the pre-
vious year’s stocks have run out but the new crop is
not yet ready for harvest. This period usually lasts
from 3 to 6 months between May and October. In the
Zinder region, in 2006, stunting among children
<5 years of age was estimated at 59% and wasting
at 11% [8].
Study participants
All children measuring 65 to <110cm (used as a
proxy for the age of 6–59 months), newly admitted
to the Mallawa and Bangaza SFCs with MAM and
good appetite were eligible for inclusion. MAM was
defined as a WHM% from 70 to <80% (NCHS ref-
erence), without oedema and with a mid-upper arm
circumference (MUAC)  110mm. Children requir-
ing hospitalization as well as those who had been
hospitalized or admitted in a nutritional programme
in the previous 2 months were excluded. Due to high
workload during the hunger gap, children with a
MUAC  135mm and apparently healthy were not
admitted to the SFP.
Study design and intervention
We conducted a field-randomized trial. The alloca-
tion sequence (blocks of 10) was computer generated
and concealed in sealed envelopes. After informed
consent of the caretaker, children were individually
randomized to receive either RUTF [Plumpy’Nut
(Nutriset, Malaunay, France) two packs daily, i.e.
1000kcalday
 1] or, as suggested in the nutritional
national protocol, a CSB pre-mix (1750g of CSB,
175ml of vegetable oil and 105g of sugar, i.e.
1231kcalday
 1). Haemoglobin concentration was
screened at admission for all children and daily iron
and folic acid supplementation was given to all chil-
dren presenting with a haemoglobin <9gdl
 1.I n
addition, in the CSB pre-mix group only, children
with a haemoglobin  9 and <11gdl
 1 were given
a weekly iron supplementation (100–200mg accord-
ing to weight), as recommended by the nutritional
national protocol. No iron supplementation was
given to children with a haemoglobin  11gdl
 1 to
prevent increased risk of malaria infection [9, 10].
Other interventions were similar in both groups
and included at admission: measles vaccination,
single vitamin A and folic acid supplementation,
deworming and malaria testing (rapid diagnosis
test: Paracheck) and treatment when positive.
Nutritional advices, medical examination and appro-
priate treatment were provided on a weekly basis.
A family ration of CSB (2450g), oil (140ml) and
sugar (140g) in separate containers was given every
week and a ration at discharge (50kg of cereals,
7.5kg of legume and 7.5l of oil).
Children were re-assessed on weekly basis until
their recovery (programme discharge criteria:
WHM%  85% for 2 consecutive weeks), death or
transfer to the I-TFC. Transfer criteria were medical
(e.g. severe infectious diseases, severe anaemia and
severe dehydration) and/or nutritional (development
of oedema, weight loss with anorexia or deterioration
of general condition). In practice, transfer decision
remained at clinician discretion. Children who did
not reach the discharge criteria after 16 weeks
of treatment were classified as ‘non-responders’.
Those who missed three consecutive visits were
classified as ‘defaulters’ and were traced by field
F. NACKERS ET AL.
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6 months after their discharge.
Study objectives
Our primary objective was to compare the weight
gain (gkg
 1day
 1) and the recovery rate in the two
groups. Secondary objectives focused on transfer to
the I-TFC, mortality, non-responder and defaulter
rates, length of stay, MUAC gain and haemoglobin
gain during treatment, relapse and height gain
6 months after discharge.
Study outcomes and data collection
Weight was measured weekly by trained staff with
100g precision using a 25kg Salter scale. Height
(children  85cm) or length (children <85cm) was
measured once every second week with 1mm preci-
sion. MUAC (left arm) was measured at admission
and at exit. Presence of oedema and Paracheck re-
sults were collected from medical records filled by
trained nurses. Haemoglobin was measured on capil-
lary blood at admission and discharge using
HemoCue 201 or 301 according to the site. A ques-
tionnaire was administered to the caretaker of the
child at admission and discharge to collect
socio-demographic characteristics, medical history
and information on adherence to the nutritional
treatment.
Sample size
To detect a 1gkg
 1day
 1 weight gain increase in the
group receiving RUTF compared to the CSB pre-mix
group (expected average weight gain SD:
2.0 2.5gkg
 1day
 1), 99 children were required
per group (80% power;  ¼0.05; two sided). To
have the same chance to detect a 10% absolute in-
crease in the cure rate in the RUTF group, we needed
313 children per group. To compensate for possible
contamination, we aimed to recruit 400 children per
group.
Statistical analysis
Data were double entered in Epidata 3.1 (Odense,
Danemark) and analysed using STATA 9 (College
Station, Texas, USA). Nutritional indicators
(NCHS reference) were calculated using EpiNut
(Epi Info 6.0). Proportions were compared by using
Chi-square tests or Fisher’s exact test when appropri-
ate. Means and medians were compared using t-tests
and Mann–Whitney tests, respectively. Weight gain
differences were estimated with their 95% confidence
intervals (CIs). Adjusted analyses were conducted
using multiple linear regression.
Ethics
The study was approved by the Comite ´ Consultatif
National d’Ethique of the Ministry of Health in
Niger and by the Comite ´ de Protection des
Personnes, Ile de France XI, Saint-Germain en
Laye, France.
Results
Recruitment took place from August to October
2007 with the 6-month follow-up ending in July
2008. During the course of the study, due to commu-
nication problems with those remote SFCs, children
weighing  8kg at any time during their treatment
were provided with three daily packs of RUTF in-
stead of two as planned in the study protocol.
Consequently, we excluded these children from the
analysis. In total, 215 children in the RUTF group
and 236 children in the CSB pre-mix group are
included in the analysis (Fig. 1). Group characteris-
tics were balanced at baseline (Table 1).
Overall recovery rate was 79.1% in the RUTF
group and 64.4% the CSB pre-mix group
(p<0.001) (Table 2). There was no statistical evi-
dence for a difference between death, defaulter and
non-responder rates. More transfers to the I-TFC
were observed in the CSB pre-mix group (19.1%)
compared to the RUTF group (9.3%) (p¼0.003).
At the time of transfer, average weight gain, age,
WHM%, length of stay in the SFP were similar in
both groups (data not shown). Reasons for transfer
did not differ between groups; 29% having been
transferred because of deterioration of their nutri-
tional status, 15% because of medical complications
and others because of a combination of both. A total
of 15 children were transferred because they had
reached a WHM% <70% or because they had de-
veloped nutritional oedema (5 in the RUTF group;
10 in the CSB pre-mix group).
The average weight gain up to discharge was
1.08gkg
 1day
 1 higher in the RUTF group com-
pared to the CSB pre-mix group (95% CI:
0.46–1.70). Among all children, the difference in
average weight gain during the first 2 weeks of treat-
ment was 1.86gkg
 1day
 1 (95% CI: 1.04–2.67) in
favour of the RUTF (Table 3). Analysis adjusted
on age, sex, WHM% at entry showed similar results
as well as analysis conducted after excluding 40 chil-
dren (21 in the RUTF group; 19 in the CSB pre-mix
group) who were discharged before or after having
reached the discharge criteria (data not shown).
Regarding the secondary outcomes, the length of
stay up to discharge was shorter in the children
receiving RUTF (median: 4 weeks vs. 6 weeks;
p<0.001). There was no evidence for a difference
in either haemoglobin or MUAC gain during treat-
ment. No adverse events attributed to the nutritional
product were reported.
At discharge, mothers reported that 82.9% of the
children receiving RUTF were able to finish the daily
ration but only 53.0% of those receiving CSB
pre-mix (p<0.001). According to the caretaker’s
information, contamination was very limited with
F. NACKERS ET AL.
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having received some RUTF or the opposite. Six
months after discharge, about one-fifth of the cured
children relapsed. During follow-up, height and
height-for-age gains were similar in children who
had received RUTF or CSB pre-mix (Table 3).
Discussion
Among children who recovered in our study,
weight gain was on average 1.08gkg
 1day
 1 higher
in the RUTF group compared to the CSB pre-mix
group. Although the recovery and eligibility criteria,
and the food protocols were different, our results fit
with previous observations in Malawian children at
risk of malnutrition, moderately malnourished or se-
verely malnourished in the second treatment phase
[4–6]. In those studies, weight gain was 0.4–
1.7gkg
 1day
 1 significantly higher in the group
receiving RUTF [4–6].
Although we do not know the proportion of the
food supplement actually eaten by the children,
>80% of the children in the RUTF group finished
their daily ration compared to only half of the chil-
dren receiving the CSB pre-mix according to the care-
takers. This had an obvious direct impact on the
weight gain. The high energy density of the RUTF
reduces significantly the food volume compared to
867 assessed for eligibility
60 excluded
56 not meeting inclusion criteria
2 refused to participate
2 other reasons
401 allocated to RUTF
1 withdrawal
182 secondarily excluded 
(programmatic reasons)
2 lost to follow-up
406 allocated to CSB premix
4 withdrawals
162 secondarily excluded 
(programmatic reasons)
1 lost to follow-up
215 analysed (1ary outcome)
1 excluded from analysis
236 analysed (1ary outcome)
3 excluded from analysis
170 discharged
27 lost to f-up at 6 months
152 discharged
26 lost to f-up at 6 months
807 randomized
FIG. 1. Flowchart of the participants.
TABLE 1
Baseline characteristics of the participants
RUTF CSB pre-mix
n¼215 n¼236
Girls 124 (57.7) 128 (54.2)
Age (months)
6–11 23 (10.8) 28 (11.9)
12–23 151 (70.9) 150 (63.8)
24–35 39 (18.3) 53 (22.6)
 36 0 (0.0) 4 (1.7)
Weight (kg) 6.6 0.7 6.6 0.7
Height (cm) 70.6 3.7 70.7 3.8
MUAC (mm) 120.9 4.9 120.0  5.6
Weight for height
(% median, NCHS)
76.7 2.6 76.4 2.4
Height for age
(Z-score, NCHS)
–2.71 0.98 –2.77 0.99
Accompanied by
their mother
201 (93.9) 218 (92.4)
Breastfed 170 (80.2) 173 (73.6)
Positive Paracheck 103 (49.5) 132 (58.4)
Haemoglobin (gdl
 1)
[4; 6[ 15 (9.2) 21 (11.7)
[6; 9[ 66 (40.5) 74 (41.3)
[9; 11[ 54 (33.1) 61 (34.1)
[11; 15[ 28 (17.2) 23 (12.9)
Data are n (%) or mean SD.
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its individual packaging, RUTF might be interpreted
as a therapeutic product and less prone to
intra-household sharing than a CSB pre-mix easily
assimilated to local food. In addition, by allowing
the caretaker to follow the nutritional advices with-
out interrupting daily activities, the ‘ready to use’
feature of RUTF might have facilitated the treatment
compared to the CSB pre-mix that should be cooked
several times a day.
Because of the higher weight gain in the RUTF
group, we observed a 2-week shorter length of stay
in the programme. This may have an important
impact on the organization of SFC (e.g. higher treat-
ment capacity with the same number of staff) and,
more importantly, it might enhance the adherence to
the nutritional treatment (e.g. caretakers are involved
for a shorter time period in the programme and
might recognize more easily the effectiveness of the
treatment).
In this study, we cannot differentiate whether the
observed accelerated weight gain is on account of
lean or fat tissue deposition. Lean tissue growth
requires appropriate nutrient intake while adipose
tissues needs mainly energy. There is some evidence
that, in Malawi [4] milk and non-milk-based RUTF
have a similar impact on weight gain despite their
different components. Therefore, indicators other
than weight gain might better assess the quality of
the nutritional recovery. We tried to approach this
issue by comparing the gain in haemoglobin level
between the two groups. Overall, there was no
evidence for a difference although this result should
be interpreted with caution since iron supplementa-
tions differed between study groups and according to
baseline level of haemoglobin. Also, the duration of
TABLE 3
Weight gain, length of stay and secondary outcomes










During the first 2 weeks (all children)
a 204 5.34 4.15 217 3.48 4.32 <0.001
Up to discharge (cured children)
b 170 5.67 3.02 152 4.59 2.59 <0.001
Length of stay up to discharge (weeks) 170 4 (2–16) 152 6 (2–16) <0.001
MUAC gain up to discharge (mmday
 1) 162 0.37 0.29 150 0.32 0.24 0.11
Haemoglobin gain up to discharge (gdl
 1week
 1) 101 0.30 0.63 102 0.29 0.51 0.77
Status 6 months after discharge 0.48
Dead 3 1.8 0 0.0
Relapse 33 19.4 33 21.7
Weight for height  80% (NCHS median) 107 62.9 93 61.2
Lost to follow-up 27 15.9 26 17.1
Height gain (mmday
 1) 6 months after discharge
c 107 0.30 0.09 93 0.31 0.10 0.67
Height for age gain (Z-score) 6 months
after discharge
c
106 0.17 0.51 93 0.16 0.50 0.86
Data are mean SD; median (minimum–maximum); or percentages.
a30 children absent, transferred or dead before the second week of treatment.
b4 children absent at the Week 2 visit.
cRelapses, dead and lost to follow-up excluded.
TABLE 2
Cure, transfer, death, defaulter and non-responder rates
RUTF CSB pre-mix Difference (%) (95% CI) p-value
n (%) n (%)
Recovered 170 (79.1) 152 (64.4) 14.7 (6.5 to 22.8) <0.001
Transfer to I-TFC 20 (9.3) 45 (19.1)  9.8 (–16.1 to –3.4) 0.003
Death 7 (3.3) 7 (3.0) 0.3 (–2.9 to 3.5) 0.86
Defaulter 5 (2.3) 11 (4.6)  2.3 (–5.7 to 1.0) 0.18
Non-responder 13 (6.0) 21 (8.9)  2.9 (–7.7 to 2.0) 0.25
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to show a measurable improvement in haemoglobin
level.
Recovery rates were better in the RUTF group
when compared to the CSB pre-mix group but this
might have been biased by the higher transfer rate to
I-TFC in the CSB group. In our study, none of the
nurses was blinded to the food product given to the
participants but, since the characteristics of children
at the time of the transfer were similar in both
groups, it is likely that similar transfer criteria were
applied for all children. This deserves further inves-
tigation since reducing the transfer rate to the I-TFC
would definitely improve the acceptability of the nu-
tritional programme by the caretakers and reduce its
cost.
We found no difference in death, non-responders,
defaulters, post-recovery relapse rates or in height
growth up to 6 months after recovery.
Supplementation with fortified spreads has been re-
ported to influence on growth [11] among moderately
malnourished children but when given for a longer
time period than in our study.
The main limitation of our study is the secondary
exclusion of children who did reach a weight of  8kg
during their treatment. This resulted in selection of
younger children, more often breastfed, with a lower
height and weight at admission. However, this sec-
ondary exclusion was evenly distributed in both
treatment groups. Child characteristics remained
balanced at baseline and our study population re-
mained relevant to address the issue of MAM in
Niger where wasting and mortality rates affect espe-
cially children <2 years of age [8].
The distribution of a weekly family and discharge
rations probably influenced not only the weight gain,
which was quite high in our study, but also the length
of stay, the recovery and defaulter rates. I am not
sure this is perfect. The message is that the rations
(both family and discharge) did influence the weight
gain, the length of stay, the recovery rate, and the
defaulter rates.
In conclusion, our study identified a series of ad-
vantages of RUTF over a CSB pre-mix for the treat-
ment of MAM in children <5 years of age in South
of Niger. These advantages have direct implications
on patients’ outcomes and management (higher
weight gain, shorter length of stay and faster recov-
ery, less transfer to the I-TFC) and might lead to a
better adherence to the treatment. Also, by increasing
organizational capacity of the SFPs, these advan-
tages would enhance the effectiveness of the nutri-
tional programmes to tackle MAM in the
community.
Currently, ready-to-use products remain more ex-
pensive than fortified blended flours but several
aspects of RUTF might significantly reduce the over-
all treatment cost. The shorter treatment duration
observed with RUTF, the limited transfer rate to
the I-TFC, its easier transport, storage, distribution
(no need to be mixed), consumption (no need to be
cooked) and, its longer shelf-life allow, on the one
hand, the SFP to save human, logistical resources
and food products. For caretakers, on the other
hand, this might limit transport and cooking fuel
expenditure, as well as opportunity costs of attending
the SFP. Economic implications of the use of
RUTF to treat MAM deserve an in-depth
evaluation.
Our results provide additional evidence on the role
of RUTF in the treatment of MAM. Further re-
search on ready-to-use food is needed to identify
the most appropriate and cost-effective product to
treat MAM.
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